A new perspective on hematological malignancies: m6A modification in immune microenvironment
S Yang, L Xu, H Zhuang, F Li, Y Lu - Frontiers in Immunology, 2024 - frontiersin.org
Immunotherapy for hematological malignancies is a rapidly advancing field that has gained
momentum in recent years, primarily encompassing chimeric antigen receptor T-cell (CAR …
momentum in recent years, primarily encompassing chimeric antigen receptor T-cell (CAR …
Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and …
B Chen, T Mao, X Qin, W Zhang, N Watanabe… - Frontiers in …, 2022 - frontiersin.org
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignancy.
Epidemiologically, the incidence of DLBCL is higher in men, and the female sex is a …
Epidemiologically, the incidence of DLBCL is higher in men, and the female sex is a …
Potential genetic therapies based on m6A methylation for skin regeneration: Wound healing and scars/keloids
X Luo, S Zhu, J Li, N Zeng, H Wang, Y Wu… - … in Bioengineering and …, 2023 - frontiersin.org
Skin wound healing is a complex and multistage process, where any abnormalities at any
stage can result in the accumulation of non-functional fibrotic tissue, leading to the formation …
stage can result in the accumulation of non-functional fibrotic tissue, leading to the formation …